Back to discover
Disease
Adenoma
Late-stage therapeutic developmentEmerging researchRising momentum
3
Publications
19
Clinical trials
1
Related conditions
2023
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2023-09-01European journal of endocrinology
Research2020-09-01Diseases of the colon and rectum
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Moderate
Key developments
- 4 clinical trials expected to report results, the earliest in Q3 2027.
Upcoming Milestones
- Q3 2027Evaluation of Patients With Suspected Parathyroid Adenoma and Negative or Equivocal 99mTc Sestamibi SPECT/CT Using 18F Fluorocholine PET/CT
- Q3 2028A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas
- Q4 2028Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal Adenoma
- Q2 2030The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma - A Multicenter, Double-blinded, Differential Design, Randomized, Placebo-controlled Study
Major developments
Upcoming trial readoutHigh impact
Results expected Q3 20272026-06-24
Upcoming trial readoutHigh impact
Results expected Q2 20302026-05-26
Clinical MilestonesViewHide
Results posted
- 2026-05-20Intraoperative Nerve Identification With Fluorescein SodiumResults posted
Results expected
- 2026-06-24Evaluation of Patients With Suspected Parathyroid Adenoma and Negative or Equivocal 99mTc Sestamibi SPECT/CT Using 18F Fluorocholine PET/CTResults expected Q3 2027
- 2026-05-26The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma - A Multicenter, Double-blinded, Differential Design, Randomized, Placebo-controlled StudyResults expected Q2 2030
- 2026-01-28Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal AdenomaResults expected Q4 2028
- 2025-12-26A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular AdenomasResults expected Q3 2028
Activity timeline6
- 2026-06-24ClinicalEvaluation of Patients With Suspected Parathyroid Adenoma and Negative or Equivocal 99mTc Sestamibi SPECT/CT Using 18F Fluorocholine PET/CTResults expected Q3 2027
- 2026-05-26ClinicalThe Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma - A Multicenter, Double-blinded, Differential Design, Randomized, Placebo-controlled StudyResults expected Q2 2030
- 2026-05-20ClinicalIntraoperative Nerve Identification With Fluorescein SodiumResults posted
- 2026-01-28ClinicalMulti-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal AdenomaResults expected Q4 2028
- 2025-12-31ClinicalStudy on the Efficacy of Hydrocortisone in Perioperative Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors:a Multicenter, Randomized, Double-blind, Placebo- Parallel Controlled StudyPrimary completion
- 2025-12-26ClinicalA Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular AdenomasResults expected Q3 2028
Clinical trials
The current development programme across all trial phases.
Clinical programme
19
6
11
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20192023
Most influential
Recent publications
Major themes7
- Adenoma1
- Adrenocortical Adenoma1
- Chemoradiotherapy1
- Cushing Syndrome1
- Frailty1
- Neoadjuvant Therapy1
- Proctectomy1
Leading journals3
- Diseases of the colon and rectum1
- European journal of endocrinology1
- Gut1
Leading researchers8
- Achenbach SJ1
- Ambroziak U1
- Athimulam S1
- Atkinson EJ1
- Bafford A1
- Baikousi DA1
- Bancos I1
- Becq A1
Affiliations (unnormalised)6
- Center for Advanced Endoscopy1
- Cleveland Clinic1
- Division of Clinical Trials and Biostatistics1
- Evangelismos Hospital1
- General Hospital Koprivnica1
- Louisiana State University School of Medicine1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A benign epithelial tumor with a glandular organization.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.